32.49
price down icon1.01%   -0.33
after-market アフターアワーズ: 32.49
loading

Supernus Pharmaceuticals Inc (SUPN) 最新ニュース

pulisher
Apr 03, 2025

ATTENTION Supernus Pharmaceuticals, Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire

Apr 03, 2025
pulisher
Apr 02, 2025

Several Supernus Pharmaceuticals Insiders Sell Shares Sending Potential Negative Signal - simplywall.st

Apr 02, 2025
pulisher
Apr 02, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Bought by HighTower Advisors LLC - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) Upgraded by StockNews.com to “Strong-Buy” Rating - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

An Investigation Has Commenced on Behalf of Supernus Pharmaceuticals, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your SUPN Losses. - ACCESS Newswire

Mar 31, 2025
pulisher
Mar 31, 2025

Thrivent Financial for Lutherans Sells 591 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

Teacher Retirement System of Texas Has $591,000 Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 31, 2025
pulisher
Mar 27, 2025

ATTENTION SUPN SHAREHOLDERS: Investors who lost money on Supernus Pharmaceuticals, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation - ACCESS Newswire

Mar 27, 2025
pulisher
Mar 26, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Acquired by Swiss National Bank - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) Downgraded to “Buy” Rating by StockNews.com - Defense World

Mar 25, 2025
pulisher
Mar 25, 2025

11,282 Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Acquired by Proficio Capital Partners LLC - Defense World

Mar 25, 2025
pulisher
Mar 25, 2025

Supernus Pharmaceuticals, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Supernus Pharmaceuticals, Inc. (SUPN) - ACCESS Newswire

Mar 25, 2025
pulisher
Mar 24, 2025

Raymond James Financial Inc. Takes $6.85 Million Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

(SUPN) Trading Report - news.stocktradersdaily.com

Mar 23, 2025
pulisher
Mar 21, 2025

SUPN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if You Lost Money on Your Supernus Pharmaceuticals, Inc. Investment - ACCESS Newswire

Mar 21, 2025
pulisher
Mar 20, 2025

PNC Financial Services Group Inc. Sells 362 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

Atria Investments Inc Invests $288,000 in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 18, 2025
pulisher
Mar 18, 2025

Charles Schwab Investment Management Inc. Purchases 40,968 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Down -20.07% in 4 Weeks, Here's Why Supernus (SUPN) Looks Ripe for a Turnaround - Yahoo Finance

Mar 17, 2025
pulisher
Mar 16, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) Upgraded to “Strong-Buy” at StockNews.com - Defense World

Mar 16, 2025
pulisher
Mar 14, 2025

Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks - Yahoo Finance

Mar 14, 2025
pulisher
Mar 13, 2025

Bank of New York Mellon Corp Boosts Stock Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Where are the Opportunities in (SUPN) - news.stocktradersdaily.com

Mar 13, 2025
pulisher
Mar 12, 2025

Smartleaf Asset Management LLC Has $47,000 Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Lost Money on Supernus Pharmaceuticals, Inc. (SUPN)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire

Mar 11, 2025
pulisher
Mar 11, 2025

Proficio Capital Partners LLC Acquires Shares of 11,282 Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 11, 2025
pulisher
Mar 08, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) Stock Rating Lowered by StockNews.com - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Supernus Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Spectrum Brands Holdings, Inc. (SPB): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts - Insider Monkey

Mar 07, 2025
pulisher
Mar 06, 2025

Supernus Pharmaceuticals, Inc. (SUPN): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts - Insider Monkey

Mar 06, 2025
pulisher
Mar 04, 2025

Supernus to Participate in Two Upcoming Investor Conferences - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

CNS Specialist Supernus Sets Investor Conference ScheduleWill You Hear What the CEO Has to Say? - StockTitan

Mar 04, 2025
pulisher
Mar 04, 2025

Lost Money on Supernus Pharmaceuticals, Inc.(SUPN)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire

Mar 04, 2025
pulisher
Mar 03, 2025

An Investigation Has Commenced on Behalf of Supernus Pharmaceuticals, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your SUPN Losses - accessnewswire.com

Mar 03, 2025
pulisher
Mar 03, 2025

Does The Market Have A Low Tolerance For Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Mixed Fundamentals? - Yahoo Finance

Mar 03, 2025
pulisher
Mar 02, 2025

Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Small Cap Pharma Stock to Buy Now? - Insider Monkey

Mar 02, 2025
pulisher
Mar 02, 2025

Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Small Cap Pharma Stocks to Buy Now? - Yahoo Finance

Mar 02, 2025
pulisher
Mar 02, 2025

(SUPN) Technical Data - Stock Traders Daily

Mar 02, 2025
pulisher
Mar 01, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Bought by Principal Financial Group Inc. - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Supernus Pharmaceuticals’ (SUPN) “Neutral” Rating Reiterated at Cantor Fitzgerald - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

StockNews.com Downgrades Supernus Pharmaceuticals (NASDAQ:SUPN) to Buy - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Decoding Supernus Pharmaceuticals Inc (SUPN): A Strategic SWOT I - GuruFocus.com

Feb 28, 2025
pulisher
Feb 28, 2025

12 Best Small Cap Pharma Stocks to Buy Now - Insider Monkey

Feb 28, 2025
pulisher
Feb 27, 2025

Supernus Pharmaceuticals’ Earnings Call Highlights Growth and Challenges - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Supernus to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewswire

Feb 27, 2025
pulisher
Feb 27, 2025

What Questions Should Investors Ask Supernus CEO at Upcoming TD Cowen Conference? - StockTitan

Feb 27, 2025
pulisher
Feb 27, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Stake Boosted by Rhumbline Advisers - Defense World

Feb 27, 2025
pulisher
Feb 27, 2025

Supernus Pharmaceuticals (SUPN) Beats Q4 Earnings and Revenue Estimates - MSN

Feb 27, 2025
pulisher
Feb 26, 2025

Supernus Pharmaceuticals Enters Oversold Territory (SUPN) - Nasdaq

Feb 26, 2025
pulisher
Feb 26, 2025

Supernus Pharmaceuticals Inc (SUPN) Reports Q4 2024 EPS of $0.27 - GuruFocus.com

Feb 26, 2025
pulisher
Feb 26, 2025

Cantor maintains neutral on Supernus, price target at $36 By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 26, 2025
pulisher
Feb 26, 2025

Supernus Pharmaceuticals Q4 Earnings, Revenue Rise; Provides 2025 Revenue Guidance - Marketscreener.com

Feb 26, 2025
$9.72
price down icon 9.75%
$31.66
price down icon 3.03%
$97.21
price down icon 0.22%
$8.16
price down icon 5.77%
$102.88
price down icon 5.01%
$307.36
price down icon 1.57%
大文字化:     |  ボリューム (24 時間):